Replies to post #10109 on Dendreon Corp fka DNDNQ

[Jimboslice]

Expecting good earnings and perhaps a buyout offer next year. This company's product called provenge is doing pretty well in sales and will have over 80 million in sales this next year (it trains your cells to fight prostate cancer). Oh, and DNDN has a very promising pipeline. It could very well be a 100 dollar stock next June. Get in soon!

[ddls]

Dendreon is doing what is called pure price gouging because of the
scope of the illness and the fact that they are trying to recover
the money it took to get it approved.

But, it's killing them, because the doctors using Provenge is not
what they thought it would be.

Bring the cost down to earth and it will get used more. Sounds
like someone screwed up at Dendreon on pricing.

This should cost 62-70k max.

[mick]

this is good,